Purchase Order 75N92B25P00216
Award Date
5/1/25
Potential Completion Date
4/30/26
Potential Value
$23K
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
339113 - Surgical Appliance and Supplies Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $19,812.90 firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract has an ultimate completion date of August 3, 2026 and was awarded on August 4, 2025. No set-aside designation was used. Illumina, a leading provider of DNA and RNA sequencing technologies, will deliver a range...
This is a firm fixed-price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for $101,126.67. The contract is for the provision of Illumina's proprietary genomic sequencing systems, reagents, and related services to support NIAMS's research and diagnostic needs. Illumina has a history of providing similar products and services to other federal...
This is a federal contract award to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis solutions, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH). The $199,073.27 firm-fixed price Delivery Order contract is for the provision of sequencing systems, reagents, and related services to support genomic research and diagnostics. This award was not subject to small business set-aside...
This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The contract has a ceiling value of $248,907.23 and runs through September 2025. There is no set-aside designation. Illumina will provide a range of its sequencing systems, consumables, and bioinformatics products to support genomic research and...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $144,182.10 contract is to provide Illumina sequencing systems, reagents, and related products and services to support genomic research and analysis at the NIH. Illumina has a history of...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The $196,882.44 contract is for the provision of various Illumina sequencing systems, consumables, and support services. Illumina has previously been awarded prime and subcontract awards by federal agencies...
This is a firm fixed price delivery order issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, to Illumina, Inc. The $101,668.72 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of sequencing and array-based analytical instruments and reagents, has previously been...
This firm fixed-price purchase order contract was awarded by the National Human Genome Research Institute, a component of the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $16,691.74 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously been awarded prime federal...
This is a delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis instruments and reagents. The $243,600.00 firm fixed price contract has a completion date of September 2, 2025 and is not a set-aside award. Illumina has provided various sequencing systems, reagents, and bioinformatics products to support genomic research and analysis across multiple...
This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. The order is for $75,832.10 and does not have a set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and consumables, is providing products and services to support genomic sequencing and analysis, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and bioinformatics support....